Black Arrow Biotech Inc.
Analysis completed on 3/17/2026
The submission raises significant red flags due to highly unrealistic claims, such as an audience reach of 'everyone' and traction stating 'most people have used my product.' For a biotech company launched in 2024, these claims are objectively unverifiable and heavily exaggerated. Additionally, reporting revenue as 'all time marketcap: 2500000' suggests this is likely a crypto-token project rather than an established biopharma firm. Due to extremely vague responses and unsupported claims, the quality factor across all metrics has been heavily penalized.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline